Clinical Trial Update: Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy of everolimus (RAD001) in breast cancer patients with bone metastases. The update indicates a Phase 2 study, with status l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN